AAPL:NASDAQApple Inc. Analysis
Data as of 2026-03-07 - not real-time
$257.46
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Apple’s stock is trading well above its discounted cash‑flow fair value, indicating a degree of overvaluation, yet it still sits below analyst median targets, leaving modest upside potential. The price is currently below its 20‑day and 50‑day moving averages, with a bearish MACD histogram and a neutral‑ish RSI, while volume has been trending down, suggesting short‑term pressure near the identified support level. Upcoming product launches – notably the iPhone 17e with MagSafe and the rollout of Apple Intelligence – are expected to reignite momentum and could help the stock retest its resistance zone.
Fundamentally, the company delivers strong revenue growth, high operating margins, robust free cash flow and a very low dividend payout ratio, supporting the sustainability of its dividend. Analyst consensus remains a “buy” with a median price target near $300, and the sector‑wide “greed” sentiment on the Fear & Greed Index further underpins a positive outlook despite the stock’s elevated beta and volatility.*
Fundamentally, the company delivers strong revenue growth, high operating margins, robust free cash flow and a very low dividend payout ratio, supporting the sustainability of its dividend. Analyst consensus remains a “buy” with a median price target near $300, and the sector‑wide “greed” sentiment on the Fear & Greed Index further underpins a positive outlook despite the stock’s elevated beta and volatility.*
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD divergence
- Decreasing volume trend
- Price approaching near‑term support
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Launch of iPhone 17e and Apple Intelligence
- Strong revenue growth and operating margins
- Analyst consensus buy with upside to median target
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Durable ecosystem and services revenue expansion
- Sustainable dividend backed by low payout ratio
- Robust cash generation and manageable debt levels
Key Metrics & Analysis
Financial Health
Revenue Growth15.70%
Profit Margin27.04%
P/E Ratio32.9
ROE152.02%
ROA24.38%
Debt/Equity102.63
P/B Ratio42.9
Op. Cash Flow$135.5B
Free Cash Flow$106.3B
Industry P/E36.2
Technical Analysis
TrendBullish
RSI40.8
Support$254.37
Resistance$280.91
MA 20$266.56
MA 50$264.29
MA 200$244.18
MACDBearish
VolumeDecreasing
Fear & Greed Index68.77
Valuation
Fair Value$191.43
Target Price$292.15
Upside/Downside13.47%
GradeFair
TypeBlend
Dividend Yield0.40%
Risk Assessment
Beta1.29
Volatility29.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.